Association Between Portal Vein Thrombosis and Pouchitis in Patients with Ulcerative Colitis.


Journal

Digestive diseases and sciences
ISSN: 1573-2568
Titre abrégé: Dig Dis Sci
Pays: United States
ID NLM: 7902782

Informations de publication

Date de publication:
04 2022
Historique:
received: 15 11 2020
accepted: 23 03 2021
pubmed: 6 5 2021
medline: 6 4 2022
entrez: 5 5 2021
Statut: ppublish

Résumé

Pouchitis is the most common long-term complication in patients requiring colectomy ileal pouch-anal anastomosis with medically refractory ulcerative colitis or colitis-associated neoplasia. A previous small case series suggests associated between portal vein thrombosis (PVT) and ischemic pouchitis. To evaluate the association between PVT and other demographic and clinical factors and pouchitis. We used Explorys Inc., a population-based database, to search medical records between 1999 and 2020 with SNOMED-CT code criteria for "construction of pouch" and "ileal pouchitis." Patients with pouchitis were compared to those with previous pouch construction without pouchitis. Factors associated with pouchitis identified with univariable analysis were introduced into a multivariable model. A post hoc analysis further stratified demographical findings of the association between PVT and pouchitis. We identified 7900 patients with ileal pouchitis (7.5%) and 97,510 with pouch construction without pouchitis. In multivariate binary logistic regression, adjusted odds ratio (aOR) for the risk of pouchitis in patients with PVT was 10.78 (95% confidence interval [CI] 7.04-16.49, P < 0.001). Other significant factors associated with pouchitis included male gender (aOR 1.11, 95% CI 1.02-1.21, P = 0.018), deep vein thrombosis (aOR 1.46, 95% CI 1.23-1.72, P < 0.001), and the use of non-steroidal anti-inflammatory drugs (aOR 1.37, 95% CI 1.28-1.45, P < 0.001). Smoking was a protective factor (aOR 0.30, 95% CI 0.33-0.36, P < 0.001). Further sub-analysis showed a higher prevalence of younger patients with PVT and pouchitis. We report PVT as an independent risk factor associated with pouchitis. Our findings support that PVT is a potentially manageable perioperative complication, and intervention may reduce the risk of pouchitis.

Sections du résumé

BACKGROUND
Pouchitis is the most common long-term complication in patients requiring colectomy ileal pouch-anal anastomosis with medically refractory ulcerative colitis or colitis-associated neoplasia. A previous small case series suggests associated between portal vein thrombosis (PVT) and ischemic pouchitis.
AIM
To evaluate the association between PVT and other demographic and clinical factors and pouchitis.
METHODS
We used Explorys Inc., a population-based database, to search medical records between 1999 and 2020 with SNOMED-CT code criteria for "construction of pouch" and "ileal pouchitis." Patients with pouchitis were compared to those with previous pouch construction without pouchitis. Factors associated with pouchitis identified with univariable analysis were introduced into a multivariable model. A post hoc analysis further stratified demographical findings of the association between PVT and pouchitis.
RESULTS
We identified 7900 patients with ileal pouchitis (7.5%) and 97,510 with pouch construction without pouchitis. In multivariate binary logistic regression, adjusted odds ratio (aOR) for the risk of pouchitis in patients with PVT was 10.78 (95% confidence interval [CI] 7.04-16.49, P < 0.001). Other significant factors associated with pouchitis included male gender (aOR 1.11, 95% CI 1.02-1.21, P = 0.018), deep vein thrombosis (aOR 1.46, 95% CI 1.23-1.72, P < 0.001), and the use of non-steroidal anti-inflammatory drugs (aOR 1.37, 95% CI 1.28-1.45, P < 0.001). Smoking was a protective factor (aOR 0.30, 95% CI 0.33-0.36, P < 0.001). Further sub-analysis showed a higher prevalence of younger patients with PVT and pouchitis.
CONCLUSIONS
We report PVT as an independent risk factor associated with pouchitis. Our findings support that PVT is a potentially manageable perioperative complication, and intervention may reduce the risk of pouchitis.

Identifiants

pubmed: 33948758
doi: 10.1007/s10620-021-06969-5
pii: 10.1007/s10620-021-06969-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1303-1310

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Shen B. Pouchitis: what every gastroenterologist needs to know. Clin Gastroenterol Hepatol. 2013;11:1538–1549.
doi: 10.1016/j.cgh.2013.03.033
Brunel M, Penna C, Tiret E, Balladur P, Parc R. Restorative proctocolectomy for distal ulcerative colitis. Gut. 1999;45:542–545.
doi: 10.1136/gut.45.4.542
Penna C, Dozois R, Tremaine W et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut. 1996;38:234–239.
doi: 10.1136/gut.38.2.234
Fazio VW, Ziv Y, Church JM et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg. 1995;222:120–127.
doi: 10.1097/00000658-199508000-00003
Ferrante M, Declerck S, De Hertogh G et al. Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Inflamm Bowel Dis. 2008;14:20–28.
doi: 10.1002/ibd.20278
Fleshner P, Ippoliti A, Dubinsky M et al. Both Preoperative Perinuclear Antineutrophil Cytoplasmic Antibody and Anti-CBir1 Expression in ulcerative colitis patients influence pouchitis development after ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol. 2008;6:561–568.
doi: 10.1016/j.cgh.2008.01.002
Gionchetti P, Rizzello F, Helwig U et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology. 2003;124:1202–1209.
doi: 10.1016/S0016-5085(03)00171-9
Simchuk EJ, Thirlby RC. Risk factors and true incidence of pouchitis in patients after ileal pouch—anal anastomoses. World J Surg. 2000;24:851–856.
doi: 10.1007/s002680010136
Schieffer KM, Williams ED, Yochum GS, Walter A, Surgery R. Review article: the pathogenesis of pouchitis. Aliment Pharmacol Ther. 2016;44:817–835.
doi: 10.1111/apt.13780
Shen B, Jiang ZD, Fazio VW et al. Clostridium difficile infection in patients with ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol. 2008;6:782–788.
doi: 10.1016/j.cgh.2008.02.021
Haneda S, Watanabe MDK, Takahashi MDK, Funayama Y, Sasaki MDI. The long-term clinical course of pouchitis after total proctocolectomy and IPAA for ulcerative colitis. Dis Colon Rectum. 2012;3:330–336.
Lohmuller JL, Pemberton JH, Dozois RR. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after iheal pouch-anal anastomosis. Ann Surg. 1990;211:622–629.
pubmed: 2339922 pmcid: 1358238
Fleshner P, Ippoliti A, Dubinsky M et al. A prospective multivariate analysis of clinical factors associated with pouchitis after ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol. 2007;5:952–958.
doi: 10.1016/j.cgh.2007.03.020
Shen B, Plesec TP, Remer E et al. Asymmetric endoscopic inflammation of the ileal pouch: a sign of ischemic pouchitis? Inflamm Bowel Dis. 2010;16:836–846.
doi: 10.1002/ibd.21129
A Wealth of Clinical Information in a Living Data Set Efficient Generation of Real-World Data for Health Informatics; 2017. http://www.ibm.com/watson/health/explorys/ . Accessed December 19, 2019.
Hill E, Abboud H, Briggs FBS. Prevalence of asthma in multiple sclerosis: a United States population-based study. Mult Scler Relat Disord. 2019;28:69–74.
doi: 10.1016/j.msard.2018.12.012
Kaelber DC, Foster W, Gilder J, Love TE, Jain AK. Patient characteristics associated with venous thromboembolic events: a cohort study using pooled electronic health record data. J Am Med Inform Assoc. 2012;19:965–972.
doi: 10.1136/amiajnl-2011-000782
Sheriff MZ, Mansoor E, Luther J et al. Opportunistic infections are more prevalent in Crohn’s disease and ulcerative colitis: a large population-based study. Inflamm Bowel Dis. 2020;26:291–300.
doi: 10.1093/ibd/izz147
Syed A, Maradey-Romero C, Fass R. The relationship between eosinophilic esophagitis and esophageal cancer. Dis Esophagus. 2017;30:1–5.
doi: 10.1093/dote/dox050
Syed AR, Thakkar P, Horne ZD et al. Old vs new: risk factors predicting early-onset colorectal cancer. World J Gastrointest Oncol. 2019;11:1011–1020.
doi: 10.4251/wjgo.v11.i11.1011
Syed A, Babich O, Thakkar P et al. Defining pancreatitis as a risk factor for pancreatic cancer: the role, incidence, and timeline of development. Pancreas. 2019;48:1098–1101.
doi: 10.1097/MPA.0000000000001367
Nadkarni PM, Darer JA. Migrating existing clinical content from ICD-9 to SNOMED. J Am Med Inform Assoc. 2010;17:602–607.
doi: 10.1136/jamia.2009.001057
Hata K, Ishihara S, Nozawa H et al. Pouchitis after ileal pouch-anal anastomosis in ulcerative colitis: diagnosis, management, risk factors, and incidence. Dig Endosc. 2017;29:26–34.
doi: 10.1111/den.12744
Gorrepati V, Stuart A, Deiling S, Koltun W, Tinsley A, Williams E. Smoking and the risk of pouchitis in ulcerative colitis patients with ileal pouch-anal anastomosis. Inflamm Bowel Dis. 2018;24:2027–2032.
doi: 10.1093/ibd/izy097
Remzi FH, Fazio VW, Oncel M et al. Portal vein thrombi after restorative proctocolectomy. Surgery. 2002;132:655–662.
doi: 10.1067/msy.2002.127689
Ball CG, MacLean AR, Buie WD, Smith DF, Raber EL. Portal vein thrombi after ileal pouch-anal anastomosis: its incidence and association with pouchitis. Surg Today. 2007;37:552–557.
doi: 10.1007/s00595-006-3470-8
Millan M, Hull TL, Hammel J, Remzi F. Portal vein thrombi after restorative proctocolectomy: serious complication without long-term sequelae. Dis Colon Rectum. 2007;50:1540–1544.
doi: 10.1007/s10350-007-0297-3
To N, Ford AC, Gracie DJ. Systematic review with meta-analysis: the effect of tobacco smoking on the natural history of ulcerative colitis. Aliment Pharmacol Ther. 2016;44:117–126.
doi: 10.1111/apt.13663
Shen B, Fazio VW, Remzi FH et al. Risk factors for diseases of ileal pouch-anal anastomosis after restorative proctocolectomy for ulcerative colitis. Clin. Gastroenterol. Hepatol. 2006;4:81–89.
doi: 10.1016/j.cgh.2005.10.004
Lewin S, McConnell R, Patel R, Sharpton S, Velayos F, Mahadevan U. Improving the quality of inpatient ulcerative colitis management: Promoting evidence-based practice and reducing care variation with an inpatient protocol. Inflamm Bowel Dis. 2019;25:1822–1827.
doi: 10.1093/ibd/izz066
Merrett MN, Mortensen N, Kettlewell M, Jewell DO. Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis. Gut. 1996;38:362–364.
doi: 10.1136/gut.38.3.362
Arora Z, Wu X, Navaneethan U, Shen B. Non-surgical porto-mesenteric vein thrombosis is associated with worse long-term outcomes in inflammatory bowel diseases. Gastroenterol. 2016;4:210–215.
Meshikhes AWN, Al-Ghazal T. Portal vein thrombosis after restorative proctocolectomy for familial adenomatous polyposis and sigmoid cancer. Case Rep Gastroenterol. 2012;6:124–130.
doi: 10.1159/000337147
Szeto W, Farraye FA. Incidence, prevalence, and risk factors for pouchitis. Semin Colon Rectal Surg. 2017;28:116–120.
doi: 10.1053/j.scrs.2017.05.002

Auteurs

Aslam Syed (A)

Division of Gastroenterology, Allegheny Health Network, Pittsburgh, PA, USA.
Department of Medicine, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, USA.

Talal Seoud (T)

Division of Gastroenterology and Hepatology, Stony Brook University Hospital, Long Island, NY, USA.

Neil M Carleton (NM)

Medical Scientist Training Program, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Shyam Thakkar (S)

Adjunct Faculty, Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA, USA.

Ravi P Kiran (RP)

Center for Inflammatory Bowel Disease, Columbia University Irving Medical Center/New York Presbyterian Hospital, Herbert Irving Pavilion-Rm 843, 161 Fort Washington Ave, New York, NY, 10032, USA.

Bo Shen (B)

Center for Inflammatory Bowel Disease, Columbia University Irving Medical Center/New York Presbyterian Hospital, Herbert Irving Pavilion-Rm 843, 161 Fort Washington Ave, New York, NY, 10032, USA. bs3270@cumc.columbia.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH